Quantcast

Posts related to ‘FDA’

Stock Split Image

Chelsea Therapeutics Rally — Speculation or Desperation?

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is rallying on Wednesday after a report in Seeking Alpha called its Northera, a treatment for symptomatic neurogenic hypotension in Parkinson's patients, a shoe-in for approval, ...
Read Full Story »
Pills

J&J, Bayer Fail to Gain FDA Approval for Blood Thinner

The U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’ ...
Read Full Story »
76764023

Arena Risk: Possible Drag on All Weight-Loss Drugs

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% ...
Read Full Story »
Pills

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

After a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However ...
Read Full Story »
76764023

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

Back in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a ...
Read Full Story »
76764023

Is There Finally a Winner in the Crowded Obesity Drug Market?

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes ...
Read Full Story »

Arena Obesity Pill Approved, Good For All Fat-Fighters (ARNA, VVUS, OREX, AGN)

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company's weight-loss drug called BELVIQ has been approved.  The news is good for all obesity drug makers today.  ...
Read Full Story »

Key Stocks To Watch For the Week Ahead, The Unusual Suspects (AAPL, BRK-A, BRK-B, BJ, C, F, GM, GPRO, IP, KND, N, NRTLQ, ONTY, SPPI, YRCW)

This last week marked another solid week for investors and many stocks were on the move.  We have compiled a list of stocks we are looking for event-driven trading moves ...
Read Full Story »

The Ten Big US Government Failures Of The 21st Century

Taxpayers are more on guard about what the federal government spends than they have been in years, or perhaps longer, as threats of a high deficit and national debt highlight ...
Read Full Story »

Food Industry Set To Become Its Own Judge And Jury

The food industry has decided to set up its own nutrition labeling system. The President's wife and FDA wanted the federal government do this. The Grocery Manufacturers Association, which represents more ...
Read Full Story »

The Ten Worst Drug Recalls In The History Of The FDA

This year's recall of certain types of Tylenol and Motrin by Johnson & Johnson (NYSE: JNJ), which began in January, brought back memories of the 1982 Tylenol recall. It affected ...
Read Full Story »

Media Digest (8/31/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   Dell (NASDAQ: DELL) is expected to stop bidding for 3Par (NYSE: PAR). Reuters:   BHP Billiton ((NYSE: BHP) says it will not divest Potash (NYSE: POT) divisions. Reuters:   Consumer spending ...
Read Full Story »

Media Digest (8/27/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   Bernanke may admit the economy is weak but not five details of the Fed's plans. Reuters:   Hewlett-Packard (NYSE: HPQ) outbid Dell (NASDAQ: DELL) for 3Par (NYSE: PAR) by offering ...
Read Full Story »

Media Digest (8/26/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   BHP Billiton (NYSE: BHP) will take its case to Potash (NYSE: POT) shareholders. Reuters:   Google In.c (NASDAQ: GOOG) will allow phone calls from Gmail accounts. Reuters:   The Bank of ...
Read Full Story »

Media Digest 7/20/2010 Reuters, WSJ, NYTimes, FT, Bloomberg

WSJ: Nokia (NYSE: NOK) will begin the search for a new CEO. Reuters:   BP plc (NYSE: BP) will continue its work on the leaking well and said seepage had nothing ...
Read Full Story »